Supernus Pharmaceuticals Newsroom

Promising Growth Prospects for Supernus Pharmaceuticals: Buy Rating Driven by Qelbree and Onapgo Market Opportunities

TipRanksMar 13 08:25 ET

Piper Sandler Maintains Supernus Pharmaceuticals(SUPN.US) With Hold Rating, Maintains Target Price $36

Moomoo NewsMar 6 07:31 ET

Piper Sandler Reaffirms Their Hold Rating on Supernus Pharmaceuticals (SUPN)

TipRanksMar 6 06:57 ET

Supernus Pharmaceuticals Price Target Maintained With a $36.00/Share by Cantor Fitzgerald

Dow JonesFeb 26 09:02 ET

Supernus Pharmaceuticals Analyst Ratings

BenzingaFeb 26 08:52 ET

Cantor Fitzgerald Downgrades Supernus Pharmaceuticals(SUPN.US) to Hold Rating, Cuts Target Price to $36

Moomoo NewsFeb 26 08:31 ET

Stifel Maintains Supernus Pharmaceuticals(SUPN.US) With Hold Rating, Maintains Target Price $38

Moomoo NewsFeb 26 08:31 ET

Piper Sandler Maintains Supernus Pharmaceuticals(SUPN.US) With Hold Rating, Maintains Target Price $36

Moomoo NewsFeb 26 07:32 ET

TD Cowen Maintains Supernus Pharmaceuticals(SUPN.US) With Buy Rating, Maintains Target Price $44

Moomoo NewsFeb 25 20:31 ET

Supernus Pharmaceuticals: Strong Buy Rating Backed by Qelbree's Growth and Promising Revenue Outlook

TipRanksFeb 25 19:52 ET

Supernus Pharmaceuticals Analyst Ratings

BenzingaFeb 19 09:53 ET

Cantor Fitzgerald Downgrades Supernus Pharmaceuticals to Neutral From Overweight, Cuts Price Target to $36 From $57

MT NewswiresFeb 19 07:40 ET

TD Cowen Maintains Supernus Pharmaceuticals(SUPN.US) With Buy Rating, Maintains Target Price $44

Moomoo NewsFeb 19 07:31 ET

Stifel Maintains Supernus Pharmaceuticals(SUPN.US) With Hold Rating, Maintains Target Price $38

Moomoo NewsFeb 4 17:31 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Pfizer (PFE) and Supernus Pharmaceuticals (SUPN)

TipRanksFeb 4 11:35 ET

TD Cowen Maintains Supernus Pharmaceuticals(SUPN.US) With Buy Rating, Raises Target Price to $44

Moomoo NewsFeb 4 11:31 ET

TD Cowen Maintains Supernus Pharmaceuticals(SUPN.US) With Buy Rating, Maintains Target Price $43

Moomoo NewsJan 29 08:31 ET

Jefferies Maintains Supernus Pharmaceuticals(SUPN.US) With Buy Rating, Maintains Target Price $40

Moomoo NewsJan 8 02:31 ET

Cantor Fitzgerald Initiates Supernus Pharmaceuticals(SUPN.US) With Buy Rating, Announces Target Price $57

Moomoo NewsJan 6 06:34 ET

Analysts Offer Insights on Healthcare Companies: Merus (MRUS), Supernus Pharmaceuticals (SUPN) and Skye Bioscience (SKYE)

TipRanksDec 6, 2024 07:26 ET